The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
A. J. Greaney, R. T. Eguia, T. N. Starr, K. Khan, N. Franko, J. K. Logue, S. M. Lord, C. Speake, H. Y. Chu, A. Sigal, J. D. Bloom
The paper examines the antibody response to the SARS-CoV-2 Delta variant, showing it targets class 1 and 2 epitopes more than class 3, and that mutations in these regions reduce antibody binding.
bioRxiv · Mar 12, 2022Microbiology